We are live on
!
Find out more
ZCI
Zevenbergen Capital Investments Portfolio holdings
AUM
$4.38B
1-Year Est. Return
56.68%
This Fund
S&P 500
This Quarter
Est. Return
+13.91%
1 Year Est. Return
+56.68%
3 Year Est. Return
+239.32%
5 Year Est. Return
+232.55%
10 Year Est. Return
+3,491.87%
AUM
$2.43B
AUM Growth
+$297M
(+14%)
Cap. Flow
+$34.6M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
49.21%
Holding
82
New
9
Increased
40
Reduced
30
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shake Shack
SHAK
|
+$25.7M |
| 2 |
Ulta Beauty
ULTA
|
+$23.2M |
| 3 |
BETR
Amplify Snack Brands, Inc.
BETR
|
+$21.6M |
| 4 |
Adobe
ADBE
|
+$16.8M |
| 5 |
ELLI
Ellie Mae Inc
ELLI
|
+$14.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$27.3M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$15.4M |
| 3 |
CELG
Celgene Corp
CELG
|
+$14.3M |
| 4 |
Baidu
BIDU
|
+$13.1M |
| 5 |
Booking.com
BKNG
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.22% |
| 2 | Communication Services | 21.96% |
| 3 | Healthcare | 16.86% |
| 4 | Technology | 13.82% |
| 5 | Industrials | 9.19% |
Similar funds
EQF
SFM
EC
FIS
CFO
CAU
NEI
Zevenbergen Capital Investments's Q3 2016 Portfolio in Review
As of Q3 2016, Zevenbergen Capital Investments held 82 positions worth $2.43B, up 14% from $2.14B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Zevenbergen Capital Investments's Q3 2016 filing shows 9 new, 40 increased, 30 reduced and 2 closed positions. Its largest new stake was Shake Shack: 694,335 shares worth $24.1M. The largest sale was Gilead Sciences, an estimated $27.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 30% a quarter earlier, followed by Communication Services and Healthcare.
- Zevenbergen Capital Investments's largest Q3 2016 buy was Shake Shack: 694,335 shares worth $24.1M.
- Zevenbergen Capital Investments added most to Ellie Mae Inc in Q3 2016, an estimated $14.7M increase.
- Zevenbergen Capital Investments's biggest Q3 2016 reduction was Celgene Corp, cutting an estimated $14.3M.
- Zevenbergen Capital Investments fully exited Gilead Sciences in Q3 2016, selling an estimated $27.3M.
- Zevenbergen Capital Investments's ten largest holdings make up 49% of its $2.43B portfolio in Q3 2016.
- Zevenbergen Capital Investments opened 9 new positions and closed 2 in Q3 2016.
- Zevenbergen Capital Investments's portfolio value rose 14% quarter-over-quarter to $2.43B.
Based on Zevenbergen Capital Investments's 13F filing for Q3 2016, filed 10 Nov 2016.